Terms: = Brain cancer AND LCK, YT16, 3932, P06239, ENSG00000182866, p56lck, pp58lck
19 results:
1. CD93 is Associated with Glioma-related Malignant Processes and Immunosuppressive Cell Infiltration as an Inspiring Biomarker of Survivance.
Ma K; Chen S; Chen X; Zhao X; Yang J
J Mol Neurosci; 2022 Oct; 72(10):2106-2124. PubMed ID: 36006582
[TBL] [Abstract] [Full Text] [Related]
2. S100A10 Is a New Prognostic Biomarker Related to the Malignant Molecular Features and Immunosuppression Process of Adult Gliomas.
Ma K; Chen S; Chen X; Yang C; Yang J
World Neurosurg; 2022 Sep; 165():e650-e663. PubMed ID: 35779750
[TBL] [Abstract] [Full Text] [Related]
3. CTSB is a negative prognostic biomarker and therapeutic target associated with immune cells infiltration and immunosuppression in gliomas.
Ma K; Chen X; Liu W; Chen S; Yang C; Yang J
Sci Rep; 2022 Mar; 12(1):4295. PubMed ID: 35277559
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human cancer.
Zheng M; Li YM; Liu ZY; Zhang X; Zhou Y; Jiang JL; Zhu P; Yang XM; Tang J; Chen ZN
Front Immunol; 2021; 12():731329. PubMed ID: 35069521
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
[TBL] [Abstract] [Full Text] [Related]
6. son is necessary for proper vertebrate blood development.
Belmonte RL; Engbretson IL; Kim JH; Cajias I; Ahn EE; Stachura DL
PLoS One; 2021; 16(2):e0247489. PubMed ID: 33630943
[TBL] [Abstract] [Full Text] [Related]
7. Increasing emergency department utilization of brain imaging in patients with primary brain cancer.
Elchoufi D; Duszak R; Balthazar P; Hanna TN; Sadigh G
Emerg Radiol; 2021 Apr; 28(2):223-231. PubMed ID: 32803458
[TBL] [Abstract] [Full Text] [Related]
8. CD96, a new immune checkpoint, correlates with immune profile and clinical outcome of glioma.
Liu F; Huang J; He F; Ma X; Fan F; Meng M; Zhuo Y; Zhang L
Sci Rep; 2020 Jul; 10(1):10768. PubMed ID: 32612110
[TBL] [Abstract] [Full Text] [Related]
9. Uridine phosphorylase 1 is a novel immune-related target and predicts worse survival in brain glioma.
Wang J; Xu S; Lv W; Shi F; Mei S; Shan A; Xu J; Yang Y
Cancer Med; 2020 Aug; 9(16):5940-5947. PubMed ID: 32583596
[TBL] [Abstract] [Full Text] [Related]
10. Large-scale analysis reveals the specific clinical and immune features of CD155 in glioma.
Liu F; Huang J; Xiong Y; Li S; Liu Z
Aging (Albany NY); 2019 Aug; 11(15):5463-5482. PubMed ID: 31377744
[TBL] [Abstract] [Full Text] [Related]
11. Beyond TCR Signaling: Emerging Functions of lck in cancer and Immunotherapy.
Bommhardt U; Schraven B; Simeoni L
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31315298
[TBL] [Abstract] [Full Text] [Related]
12. Preventing lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts.
Suryadevara CM; Desai R; Farber SH; Choi BD; Swartz AM; Shen SH; Gedeon PC; Snyder DJ; Herndon JE; Healy P; Reap EA; Archer GE; Fecci PE; Sampson JH; Sanchez-Perez L
Clin Cancer Res; 2019 Jan; 25(1):358-368. PubMed ID: 30425092
[TBL] [Abstract] [Full Text] [Related]
13. Regulation of human glioma cell migration, tumor growth, and stemness gene expression using a lck targeted inhibitor.
Zepecki JP; Snyder KM; Moreno MM; Fajardo E; Fiser A; Ness J; Sarkar A; Toms SA; Tapinos N
Oncogene; 2019 Mar; 38(10):1734-1750. PubMed ID: 30353164
[TBL] [Abstract] [Full Text] [Related]
14. Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas.
Wang PF; Cai HQ; Zhang CB; Li YM; Liu X; Wan JH; Jiang T; Li SW; Yan CX
J Neuroinflammation; 2018 May; 15(1):145. PubMed ID: 29764444
[TBL] [Abstract] [Full Text] [Related]
15. Identification of targets for rational pharmacological therapy in childhood craniopharyngioma.
Gump JM; Donson AM; Birks DK; Amani VM; Rao KK; Griesinger AM; Kleinschmidt-DeMasters BK; Johnston JM; Anderson RC; Rosenfeld A; Handler M; Gore L; Foreman N; Hankinson TC
Acta Neuropathol Commun; 2015 May; 3():30. PubMed ID: 25990246
[TBL] [Abstract] [Full Text] [Related]
16. Transgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activity.
Kosaka A; Ohkuri T; Ikeura M; Kohanbash G; Okada H
Biochem Biophys Res Commun; 2015 Mar; 458(3):549-554. PubMed ID: 25677619
[TBL] [Abstract] [Full Text] [Related]
17. Role of lymphocyte-specific protein tyrosine kinase (lck) in the expansion of glioma-initiating cells by fractionated radiation.
Kim RK; Yoon CH; Hyun KH; Lee H; An S; Park MJ; Kim MJ; Lee SJ
Biochem Biophys Res Commun; 2010 Nov; 402(4):631-6. PubMed ID: 20971076
[TBL] [Abstract] [Full Text] [Related]
18. Regulation of lck and Fyn tyrosine kinase activities by transmembrane protein tyrosine phosphatase leukocyte common antigen-related molecule.
Tsujikawa K; Ichijo T; Moriyama K; Tadotsu N; Sakamoto K; Sakane N; Fukada S; Furukawa T; Saito H; Yamamoto H
Mol Cancer Res; 2002 Dec; 1(2):155-63. PubMed ID: 12496362
[TBL] [Abstract] [Full Text] [Related]
19. T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors.
Morford LA; Elliott LH; Carlson SL; Brooks WH; Roszman TL
J Immunol; 1997 Nov; 159(9):4415-25. PubMed ID: 9379040
[TBL] [Abstract] [Full Text] [Related]
